INDIVIDUAL TEST 838

Glycine receptor (GlyR) antibodies

IndicationSuspected Stiff person syndrome and especially PERM (Progressive encephalomyelitis with rigidity and myoclonus).MethodThe assay is performed by indirect immuno fluorescence (IIF).AnswerThe answer is given as titer. InterpretationThe analysis establishes if the patient sample contains autoantibodies against the glycine receptor (GlyR). Publications show that in most cases the antibodies bind to the glycine receptor alpha 1 (GlyRalfa 1). These antibodies are particularly associated with PERM (Progressive encephalomyelitis with rigidity and myoclonus) and Stiff person syndrome. In less than 10% of the cases, the anti-GlyR positive patients showed a correlation with paraneoplastic cancers.

The antigen is a sub unit to pentameric inhibitory glycine receptor. This receptor mediates postsynaptic inhibition of the central nervous system.

Generally, treatment with immunotherapy is more effective against auto-antibodies directed to extracellular antigen than with auto-antibodies against intracellular antigens.

References:PMID: 15342008: 15258215: 21747075: 22448032; PMCID: Alpha

 

More information

Learn more about sampling.
> Read more

Download request forms

Neurology

ENSKILD ANALYS 838

Glycinreceptor-antikroppar

IndikationMisstanke om Stiff person syndrom och framför allt PERM (Progressiv encefalomyelit med rigiditet och myoklonier).MetodAnalysen utföres med indirekt immunofluorescens (IIF). SvarSvaret anges som titer. TolkningAnalysen ger svar om patientprovet innehåller autoantikroppar riktade mot Glycinreceptor (GlyR). Publikationer visar att i flesta tillfällen binder antikropparna till Glycinreceptor alfa 1 (GlyRalfa 1). Dessa antikroppar är framför allt associerade med  varianten PERM (Progressiv encefalomyelit med rigiditet och myoklonier) vid stiff person syndrom. I mindre än 10% av fallen har anti-GlyR positiva patienter visat en korrelation med paraneoplastiska cancerformer. Antigenet är en subenhet till pentameric inhibitory glycine receptor. Denna receptor medierar postsynaptisk inhibering i det centrala nervsystemet. Generellt sett är behandling med immunoterapi oftare effektfull vid auto-antikroppar riktade mot extracellulära antigen än vid auto-antikroppar mot intracellulära antigen.   Referenser: PMID: 15342008; 15258215; 21747075; 22448032; PMCID: PMC3348613

Mer information

Mer information om provtagning.
> Läs mer

Ladda ner remiss

Neurologi